Paion AG (LTS:0NF3) FFO


LTS:0NF3 Paion AG LTS:0NF3
10 GF Score
Price €0.01
View Full Analysis

What is Paion AG FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0NF3
10GF Score
Paion AG LTS:0NF3
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paion AG Business Description

Address Heussstrasse 25, Aachen, DEU, 52078
Paion AG is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
10GF Score

Get the complete analysis for LTS:0NF3

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price